BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15722115)

  • 1. Nitric oxide and neurological disorders.
    Duncan AJ; Heales SJ
    Mol Aspects Med; 2005; 26(1-2):67-96. PubMed ID: 15722115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
    Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
    In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide and reactive oxygen species in Parkinson's disease.
    Tieu K; Ischiropoulos H; Przedborski S
    IUBMB Life; 2003 Jun; 55(6):329-35. PubMed ID: 12938735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
    Mariani E; Polidori MC; Cherubini A; Mecocci P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physiology and pathophysiology of nitric oxide in the brain.
    Guix FX; Uribesalgo I; Coma M; Muñoz FJ
    Prog Neurobiol; 2005 Jun; 76(2):126-52. PubMed ID: 16115721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria as targets for chemotherapy.
    Gogvadze V; Orrenius S; Zhivotovsky B
    Apoptosis; 2009 Apr; 14(4):624-40. PubMed ID: 19205885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide, S-nitrosylation and neurodegeneration.
    Chung KK; Dawson TM; Dawson VL
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(3):247-54. PubMed ID: 16191392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species and the neurodegenerative disorders.
    Knight JA
    Ann Clin Lab Sci; 1997; 27(1):11-25. PubMed ID: 8997453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitric oxide in Parkinson's disease.
    Zhang L; Dawson VL; Dawson TM
    Pharmacol Ther; 2006 Jan; 109(1-2):33-41. PubMed ID: 16005074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms.
    Pannu R; Singh I
    Neurochem Int; 2006 Jul; 49(2):170-82. PubMed ID: 16765486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Complex I: structure, function, and implications in neurodegeneration.
    Lenaz G; Baracca A; Fato R; Genova ML; Solaini G
    Ital J Biochem; 2006; 55(3-4):232-53. PubMed ID: 17274529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropharmacologic aspects of apoptosis: significance for neurodegenerative diseases.
    Michel PP; Lambeng N; Ruberg M
    Clin Neuropharmacol; 1999; 22(3):137-50. PubMed ID: 10367178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of protein nitration in brain injury: a key pathophysiological mechanism in neurodegenerative, autoimmune, or inflammatory CNS diseases and stroke.
    Sarchielli P; Galli F; Floridi A; Floridi A; Gallai V
    Amino Acids; 2003 Dec; 25(3-4):427-36. PubMed ID: 14661102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of astroglial cell-derived nitric oxide and prostanoids in neurodegenerative disorders.
    Mollace V; Muscoli C; Nisticò G
    Funct Neurol; 1997; 12(3-4):199-203. PubMed ID: 9218977
    [No Abstract]   [Full Text] [Related]  

  • 19. Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease.
    Carreras MC; Franco MC; Peralta JG; Poderoso JJ
    Mol Aspects Med; 2004; 25(1-2):125-39. PubMed ID: 15051322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide, cell bioenergetics and neurodegeneration.
    Moncada S; Bolaños JP
    J Neurochem; 2006 Jun; 97(6):1676-89. PubMed ID: 16805776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.